Salivary Gland Tumor Banking and Clinical Review


About this study

The purpose of establishing the salivary gland tissue biobank is to learn how to improve our ability to diagnose and treat salivary gland tumors.  Specifically, we will be evaluating DNA, RNA, and protein in tumors and normal tissue/blood. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Please contact the study team to discuss whether or not you are eligible to participate in a study.

Inclusion Criteria:    

  • Adult male and female patients, over 18 years
  • Children male and female patients, over 14 years
  • Adult pregnant woman over 18 years that are undergoing surgical treatment for salivary gland diseases.
    • Only patients with tumors involving the major or minor salivary glands that require surgical removal before normal delivery would be eligble for enrollement. 

Exclusion Criteria:   

  • Patients under the age of 14 
  • Unable to give informed consent   

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Joaquin Garcia, M.D.

Contact us for the latest status

Contact information:

Nicole Tombers R.N., CCRP


More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions